Health
South African SARS-CoV-2 variant most problematic for BNT-162b2 vaccine – News-Medical.Net
Researchers from Germany and the US investigated the efficacy of neutralizing antibodies against newer variants using serum and saliva samples obtained from groups…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late December 2019 in Wuhan, China. The virus has since spread across the globe, evolving into the COVID-19 pandemic, crippling global public health systems and economies. The scientific community sprang into action and made unprecedented strides in vaccine research and development, leading to the generation of multiple vaccines for COVID-19, utilizing various approaches. However, SARS-CoV-2 is parallelly evolving into newer…
-
Business6 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
Business13 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News8 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed
-
Noosa News7 hours agoLady Gaga announces first Australian shows in 11 years